This technology company beat earnings estimates by $0.03 last quarter, and is forecast to post double-digit growth.
Thermo Fisher Scientific (TMO)
From The Complete Investor
This tech company offers the kinds of products that should remain in demand even if the economy turns volatile. Massachusetts-based Thermo Fisher Scientific (TMO) is a leading health care company that develops, manufactures, and sells advanced medical equipment and technology.
Its products are used by research scientists, laboratories, and hospitals to help in disease diagnosis and in the discovery and production of new vaccines and drugs. With 50,000 employees worldwide and a market capitalization of $57.9 billion, the company is a dominant player in the lab products, life sciences, diagnostics, and analytical instrumentation sectors.
The company has a history of making smart acquisitions that have boosted growth, and in 2016 it made two more than should keep the trend going. In January, Thermo Fisher acquired Affymetrix for $1.3 billion, enhancing its position in genetic analysis and bioscience research tools. A few months later it purchased electron microscope manufacturer FEI Co. for $4.2 billion. Thermo Fisher projects 2016 revenue growth of 8%.
Stephen Leeb, PhD. And Genia Turanova, The Complete Investor, www.completeinvestor.com, 866-833-2070, February 2017